Pharma Department showcases Indian MedTech innovations at IITF 2026

New Delhi: Department of Pharmaceuticals is showcasing Indian pharmaceutical and MedTech innovations at the 45th India International Trade Fair (IITF) 2026 in New Delhi. The exhibition features products and technologies developed by 10 startups supported under the Promotion of Research and Innovation in Pharma-MedTech (PRIP) scheme. The stalls are open from November 19 to 23 at Bharat Mandapam.

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, sponsored the stalls in the fair’s ‘Hall of Inspiration’. It organised the showcase in collaboration with the Department for Promotion of Industry and Internal Trade (DPIIT). The India Trade Promotion Organisation (ITPO) is organising the trade fair.

Shri Awadhesh Kumar Choudhary, Senior Economic Advisor in the Department of Pharmaceuticals, inaugurated the stalls on November 19. Senior officers and officials of the Department attended the inauguration.

Startups highlight MedTech innovations and advanced therapies

The 10 participating startups are presenting technologies across diagnostics, medical devices and advanced therapies. These MedTech innovations include AI-powered microscopes and automated diagnostic machines for disease detection. Some systems use genetic testing to detect tuberculosis.

The display also features affordable AI-enabled bionic ear implants and rehabilitation devices for people with hearing impairment. In addition, protective surgical helmets have been developed for doctors performing complex procedures, including hip and knee replacements.

The showcase includes technologies for developing advanced vaccines and biological medicines. It also features 3D tumour models that can help assess the effectiveness of chemotherapy treatments. Other innovations include implantable bone-lengthening devices for limb reconstruction.

Startups are also presenting CAR-T cell therapies for blood cancers and gene therapies for inherited blood disorders. Meanwhile, AI-designed oral medicines under development target obesity and diabetes.

The participating companies are further displaying regenerative medicine technologies. These are intended to repair damaged tissues and address conditions affecting the eyes, liver and lungs. Portable blood-testing machines capable of delivering blood count results in 10 minutes are also on display.

The exhibition additionally features affordable, indigenous molecular diagnostic kits and machines. These technologies can detect infections such as tuberculosis and COVID-19.

The initiative reflects the Department’s efforts to promote indigenous innovation and strengthen Indian pharmaceutical and MedTech startups. It also aims to support a competitive, innovation-driven ecosystem for the country’s pharmaceutical and medical technology sectors.